echinacoside

10/01/2023 - "Conclusions Our research found that echinacoside has antitumor properties that resulted in a substantial decrease in tumor size and weight, leading to an increase in the average survival time of rats and an improvement in muscle structure. "
10/01/2023 - "This study explored the potential anti-cancer benefits of echinacoside in rats with ESC. "
01/01/2024 - "Echinacoside (ECH) is a natural anti-cancer compound and is of great value in cancer treatment. "
04/01/2022 - "Further, in vivo results showed that Echinacoside could effectively alleviate the tumor growth of xenograft mice, accompanied by the decrease of PI3K/AKT signaling. "
04/01/2022 - "Finally, the anti-tumor effect of Echinacoside on SKOV3-xenografted mice was evaluated by xenograft tumor mouse model. "

08/01/2018 - "In this study, we investigated the protective effects of echinacoside on cardiomyocytes (rat H9c2 cells) in an anoxia/reperfusion (A/R) model. "
01/01/2014 - "The main purpose of this study is to evaluate the effect of echinacoside (ECH) on hypoxia-induced proliferation of rat pulmonary artery smooth muscle cells (PASMCs) and the underlying mechanism. "
04/01/2019 - "Echinacoside alleviates hypobaric hypoxia-induced memory impairment in C57 mice."
01/01/2014 - "Antiproliferative effect of echinacoside on rat pulmonary artery smooth muscle cells under hypoxia."
12/01/2018 - "Letter to the editor regarding the article by Chen et al. entitled "Protective effects of echinacoside against anoxia/reperfusion injury in H9c2 cells via up-regulating p-AKT and SLC8A3"."

07/01/2022 - "We aimed to evaluate the effect of echinacoside (ECH), which is known to modulate inflammation and apoptosis on IC using relevant models. "
08/01/2018 - "Echinacoside alleviated LPS-induced cell apoptosis and inflammation in rat intestine epithelial cells by inhibiting the mTOR/STAT3 pathway."
10/01/2023 - "Effects of Echinacoside on Ehrlich Carcinoma in Rats by Targeting Proliferation, Hypoxia and Inflammation."
10/01/2023 - "Additionally, echinacoside was shown to ameliorate hypoxia by suppressing HIF-1α, reduce inflammation by decreasing NFκB and TNF-α, decrease proliferation by reducing PI3K, and block cyclin D1 and CDK2 to inhibit differentiation."
08/01/2022 - "Echinacoside (ECH), a phenylethanoid glycoside, has protective activity in neurodegenerative disease, including anti-inflammation and antioxidation. "

12/01/2018 - "Letter to the editor regarding the article by Chen et al. entitled "Protective effects of echinacoside against anoxia/reperfusion injury in H9c2 cells via up-regulating p-AKT and SLC8A3"."
08/01/2018 - "Protective effects of echinacoside against anoxia/reperfusion injury in H9c2 cells via up-regulating p-AKT and SLC8A3."

07/01/2013 - "Application of two-phase hollow fiber liquid phase microextraction coupled with high-performance liquid chromatography for the study of the echinacoside pharmacokinetics in Parkinson's disease rat plasma."
11/19/2023 - "Echinacoside (ECH), a natural active compound, was found to exert neuroprotection in Parkinson's disease (PD). "
01/01/2022 - "Echinacoside (ECH), the major active constituent of Cistanche deserticola, was found to exert neuroprotection through neurotrophic and anti-inflammatory functions in Parkinson's disease (PD) models. "
01/01/2022 - "Echinacoside Protects Dopaminergic Neurons Through Regulating IL-6/JAK2/STAT3 Pathway in Parkinson's Disease Model."
07/01/2013 - "The validated method has been successfully applied for pharmacokinetic studies of echinacoside in Parkinson's disease (PD) rat plasma after oral administration."